- Query in any language with multilingual search
- Access EUR-Lex and EU Commission case law
- See relevant paragraphs highlighted instantly
Similar Documents
Explore similar documents to your case.We Found Similar Cases for You
Case T-380/18: Judgment of the General Court of 7 November 2019 — Intas Pharmaceuticals v EUIPO — Laboratorios Indas (INTAS) (EU trade mark — Opposition proceedings — Application for the EU word mark INTAS — Earlier EU and national figurative trade marks including the word element ‘indas’ — Relative ground for refusal — Likelihood of confusion — Similarity of the signs and of the goods — Article 8(1)(b) of Regulation (EU) 2017/1001 — Proof of genuine use of the earlier marks — Article 47 of Regulation 2017/1001)
ECLI:EU:UNKNOWN:62018TA0380
62018TA0380
With us you find everything. Try it now!
I imagine what I want to write in my case, I write it in the search engine and I get exactly what I wanted. Thank you!
Valentina R., lawyer
23.12.2019
Official Journal of the European Union
C 432/42
(Case T-380/18) (*)
(EU trade mark - Opposition proceedings - Application for the EU word mark INTAS - Earlier EU and national figurative trade marks including the word element ‘indas’ - Relative ground for refusal - Likelihood of confusion - Similarity of the signs and of the goods - Article 8(1)(b) of Regulation (EU) 2017/1001 - Proof of genuine use of the earlier marks - Article 47 of Regulation 2017/1001)
(2019/C 432/48)
Language of the case: English
Parties
Applicant: Intas Pharmaceuticals Ltd (Ahmedabad, India) (represented by: F. Traub, lawyer)
Defendant: European Union Intellectual Property Office (represented by: J. Crespo Carrillo and H. O’Neill, acting as Agents)
Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Laboratorios Indas, SA (Pozuelo de Alarcón, Spain) (represented by: A. Gómez López, lawyer)
Re:
Action brought against the decision of the Fourth Board of Appeal of EUIPO of 16 April 2018 (Case R 815/2017-4), relating to opposition proceedings between Laboratorios Indas and Intas Pharmaceuticals.
Operative part of the judgment
The Court:
1.Dismisses the action;
2.Orders Intas Pharmaceuticals Ltd to pay the costs.
(*)
Language of the case: English.
ECLI:EU:C:2019:140